306 related articles for article (PubMed ID: 20516248)
1. Incidence, outcomes, and management of bleeding in non-ST-elevation acute coronary syndromes.
Gutierrez A; Rao SV
Cleve Clin J Med; 2010 Jun; 77(6):369-79. PubMed ID: 20516248
[TBL] [Abstract][Full Text] [Related]
2. Tailored antithrombotic therapy for acute coronary syndromes.
Fitchett D
Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):935-44. PubMed ID: 18666844
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet therapy: anti-ischemic benefits versus bleeding risk.
Gibson CM
J Interv Cardiol; 2008 Dec; 21 Suppl 1():S3-9. PubMed ID: 19090934
[TBL] [Abstract][Full Text] [Related]
4. A risk score to predict bleeding in patients with acute coronary syndromes.
Mehran R; Pocock SJ; Nikolsky E; Clayton T; Dangas GD; Kirtane AJ; Parise H; Fahy M; Manoukian SV; Feit F; Ohman ME; Witzenbichler B; Guagliumi G; Lansky AJ; Stone GW
J Am Coll Cardiol; 2010 Jun; 55(23):2556-66. PubMed ID: 20513595
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal bleeding in percutaneous coronary intervention and acute coronary syndromes.
Nikolsky E; Mehran R; Stone GW
Am J Cardiol; 2009 Sep; 104(5 Suppl):22C-9C. PubMed ID: 19695357
[TBL] [Abstract][Full Text] [Related]
6. The score is in but is the decision final?
Brinker J
J Am Coll Cardiol; 2010 Jun; 55(23):2567-9. PubMed ID: 20513596
[No Abstract] [Full Text] [Related]
7. Avoiding and managing bleeding complications in patients with non-ST-segment elevation acute coronary syndromes.
Potsis TZ; Katsouras C; Goudevenos JA
Angiology; 2009; 60(2):148-58. PubMed ID: 18508853
[TBL] [Abstract][Full Text] [Related]
8. Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes.
Rao SV; Kaul PR; Liao L; Armstrong PW; Ohman EM; Granger CB; Califf RM; Harrington RA; Eisenstein EL; Mark DB
Am Heart J; 2008 Feb; 155(2):369-74. PubMed ID: 18215610
[TBL] [Abstract][Full Text] [Related]
9. Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy.
Chew DP; Huang Z; Pieper KS; White H; Mahaffey KW; Ferguson JJ; Califf RM; Aylward PG
Am Heart J; 2008 Feb; 155(2):239-44. PubMed ID: 18215592
[TBL] [Abstract][Full Text] [Related]
10. The medical management of acute coronary syndromes and potential roles for new antithrombotic agents.
Pollack CV; Goldberg AD
J Emerg Med; 2008 May; 34(4):417-28. PubMed ID: 18226874
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications and management of bleeding events in patients with acute coronary syndromes.
De Luca L; Casella G; Lettino M; Fradella G; Toschi V; Conte MR; Ottani F; Geraci G; Visconti LO; Tubaro M; Maggioni AP
J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):677-86. PubMed ID: 19531962
[TBL] [Abstract][Full Text] [Related]
12. Assessing bleeding risk in acute coronary syndromes.
Erdem G; Flather M
Rev Esp Cardiol (Engl Ed); 2012 Jan; 65(1):4-6. PubMed ID: 22056593
[No Abstract] [Full Text] [Related]
13. Evolving antithrombotic treatment strategies for acute ST-elevation myocardial infarction.
Kandzari DE
Rev Cardiovasc Med; 2006; 7 Suppl 4():S29-37. PubMed ID: 17224888
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet agents in acute coronary syndromes.
Sakhuja R; Yeh RW; Bhatt DL
Curr Probl Cardiol; 2010 Mar; 35(3):123-70. PubMed ID: 20152547
[TBL] [Abstract][Full Text] [Related]
15. Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction.
Manoukian SV
Am J Cardiol; 2009 Sep; 104(5 Suppl):9C-15C. PubMed ID: 19695355
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic treatment in acute coronary syndromes.
Hoole SP; Saw J
Minerva Med; 2010 Aug; 101(4):215-38. PubMed ID: 21030935
[TBL] [Abstract][Full Text] [Related]
17. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
Rubboli A; Halperin JL
Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
[No Abstract] [Full Text] [Related]
18. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
Roldán V; Marín F
Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
[No Abstract] [Full Text] [Related]
19. [Reduction of haemorrhagic risk in acute coronary syndromes].
Merino A; Roldán I; Marín F; Worner F;
Med Clin (Barc); 2011 Nov; 137(14):650-5. PubMed ID: 20701931
[No Abstract] [Full Text] [Related]
20. Dual antiplatelet therapy and antithrombotic treatment: Recommendations and controversies.
Bryniarski L; Pelc-Nowicka A; Zabojszcz M; Mirek-Bryniarska E
Cardiol J; 2009; 16(2):179-89. PubMed ID: 19387970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
